Skip to main content

Advertisement

SpringerLink
Log in

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The progression of ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) marks a critical step in the evolution of breast cancer. There is some evidence to suggest that dynamic interactions between the neoplastic cells and the tumour microenvironment play an important role. Using the whole-genome cDNA-mediated annealing, selection, extension and ligation assay (WG-DASL, Illumina), we performed gene expression profiling on 87 formalin-fixed paraffin-embedded (FFPE) samples from 17 patients consisting of matched IDC, DCIS and three types of stroma: IDC-S (<3 mm from IDC), DCIS-S (<3 mm from DCIS) and breast cancer associated-normal stroma (BC-NS; >10 mm from IDC or DCIS). Differential gene expression analysis was validated by quantitative real time-PCR, immunohistochemistry and immunofluorescence. The expression of several genes was down-regulated in stroma from cancer patients relative to normal stroma from reduction mammoplasties. In contrast, neoplastic epithelium underwent more gene expression changes during progression, including down regulation of SFRP1. In particular, we observed that molecules related to extracellular matrix (ECM) remodelling (e.g. COL11A1, COL5A2 and MMP13) were differentially expressed between DCIS and IDC. COL11A1 was overexpressed in IDC relative to DCIS and was expressed by both the epithelial and stromal compartments but was enriched in invading neoplastic epithelial cells. The contributions of both the epithelial and stromal compartments to the clinically important scenario of progression from DCIS to IDC. Gene expression profiles, we identified differential expression of genes related to ECM remodelling, and specifically the elevated expression of genes such as COL11A1, COL5A2 and MMP13 in epithelial cells of IDC. We propose that these expression changes could be involved in facilitating the transition from in situ disease to invasive cancer and may thus mark a critical point in disease development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

BC-NS:

Breast cancer normal stroma

DCIS:

Ductal carcinoma in situ

DCIS-S:

DCIS-stroma

ECM:

Extracellular matrix

FF:

Fresh frozen

FFPE:

Formalin fixed paraffin embedded

IDC:

Invasive ductal carcinoma

IDC-S:

IDC-stroma

IF:

Immunofluorescence

IHC:

Immunohistochemistry

ILC:

Invasive lobular carcinoma

LCM:

Laser capture microdissection

NE:

Normal epithelium

qRT-PCR:

Quantitative real time-PCR

RM:

Reduction mammoplasty

RM-NS:

Reduction mammoplasty normal stroma

WG-DASL:

Whole-genome cDNA-mediated annealing, selection, extension and ligation assay

References

  1. Wellings SR, Jensen HM (1973) On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 50(5):1111–1118

    PubMed  CAS  Google Scholar 

  2. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR (2005) Molecular evolution of breast cancer. J Pathol 205(2):248–254

    Article  PubMed  CAS  Google Scholar 

  3. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS (2010) Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 57(2):171–192

    Article  PubMed  Google Scholar 

  4. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, Zhou YX, Varnholt H, Smith B, Gadd M, Chatfield E, Kessler J, Baer TM, Erlander MG, Sgroi DC (2003) Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100(10):5974–5979

    Article  PubMed  CAS  Google Scholar 

  5. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11(1):R7

    Article  PubMed  Google Scholar 

  6. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ (2006) Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res 66(10):5278–5286

    Article  PubMed  CAS  Google Scholar 

  7. Castro NP, Osorio CA, Torres C, Bastos EP, Mourao-Neto M, Soares FA, Brentani HP, Carraro DM (2008) Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10(5):R87

    Article  PubMed  Google Scholar 

  8. Gao Y, Niu Y, Wang X, Wei L, Lu S (2009) Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. J Mol Med 87(2):145–152

    Article  PubMed  CAS  Google Scholar 

  9. Lakhani SR, Collins N, Stratton MR, Sloane JP (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48(7):611–615

    Article  PubMed  CAS  Google Scholar 

  10. Heaphy CM, Bisoffi M, Joste NE, Baumgartner KB, Baumgartner RN, Griffith JK (2009) Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat 117:17–24

    Article  PubMed  CAS  Google Scholar 

  11. Knudsen ES, Ertel A, Davicioni E, Kline J, Schwartz GF, Witkiewicz AK (2011) Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res Treat [Epub ahead of print]

  12. Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, van de Vijver MJ, West RB, van de Rijn M, Koller D (2011) Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 3(108):108–113

    Article  Google Scholar 

  13. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14(5):518–527

    Article  PubMed  CAS  Google Scholar 

  14. West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussard T, Goldblum JR, Brown PO, van de Vijver M, van de Rijn M (2005) Determination of stromal signatures in breast carcinoma. PLoS Biol 3(6):e187

    Article  PubMed  Google Scholar 

  15. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2(2):E7

    Article  PubMed  Google Scholar 

  16. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, Andre S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15(1):68–74

    Article  PubMed  CAS  Google Scholar 

  17. Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, da Silva L, Vargas AC, Reid L, Simpson PT, Lakhani SR, Chenevix-Trench G (2010) Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. J Pathol 221(4):452–461

    PubMed  CAS  Google Scholar 

  18. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, Cox D, Jones W, Rubio R, Holton K, Matulonis U, Quackenbush J, Fan JB (2009) Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS ONE 4(12):e8162

    Article  PubMed  Google Scholar 

  19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  20. Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon

    Google Scholar 

  21. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410

    Article  PubMed  CAS  Google Scholar 

  22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408

    Article  PubMed  CAS  Google Scholar 

  23. Du P, Kibbe WA, Lin SM (2008) Lumi: a pipeline for processing Illumina microarray. Bioinformatics 24(13):1547–1548

    Article  PubMed  CAS  Google Scholar 

  24. Smyth GK, Michaud J, Scott HS (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21(9):2067–2075

    Article  PubMed  CAS  Google Scholar 

  25. Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, Mian IS, Borowsky AD, Jensen RA, Idowu MO, Chen F, Chen DJ, Petersen OW, Gray JW, Bissell MJ (2008) A human breast cell model of preinvasive to invasive transition. Cancer Res 68(5):1378–1387

    Article  PubMed  CAS  Google Scholar 

  26. Delassus GS, Cho H, Eliceiri GL (2011) New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol 226(12):3378–3384

    Article  PubMed  CAS  Google Scholar 

  27. Bowen KB, Reimers AP, Luman S, Kronz JD, Fyffe WE, Oxford JT (2008) Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. J Histochem Cytochem 56(3):275–283

    Article  PubMed  CAS  Google Scholar 

  28. Fischer H, Salahshor S, Stenling R, Bjork J, Lindmark G, Iselius L, Rubio C, Lindblom A (2001) COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 1:17

    Article  PubMed  CAS  Google Scholar 

  29. Fischer H, Stenling R, Rubio C, Lindblom A (2001) Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 22(6):875–878

    Article  PubMed  CAS  Google Scholar 

  30. Halsted KC, Bowen KB, Bond L, Luman SE, Jorcyk CL, Fyffe WE, Kronz JD, Oxford JT (2008) Collagen alpha1(XI) in normal and malignant breast tissue. Mod Pathol 21(10):1246–1254

    Article  PubMed  CAS  Google Scholar 

  31. Nonaka D, Chiriboga L, Rubin BP (2008) Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol 32(9):1291–1298

    Article  PubMed  Google Scholar 

  32. Yang ZQ, Liu G, Bollig-Fischer A, Haddad R, Tarca AL, Ethier SP (2009) Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer 125(7):1613–1621

    Article  PubMed  CAS  Google Scholar 

  33. Webb TR, Clark AJ (2010) Minireview: the melanocortin 2 receptor accessory proteins. Mol Endocrinol 24(3):475–484

    Article  PubMed  CAS  Google Scholar 

  34. Saeki T, Tsuruo T, Sato W, Nishikawsa K (2005) Drug resistance in chemotherapy for breast cancer. Cancer Chemother Pharmacol 56(Suppl 1):84–89

    Article  PubMed  Google Scholar 

  35. Krech T, Scheuerer E, Geffers R, Kreipe H, Lehmann U, Christgen M (2012) ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells. Cancer Lett 315(2):153–160

    Article  PubMed  CAS  Google Scholar 

  36. Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, Hanker L, Gaetje R, Solbach C, Ahr A, Metzler D, Schmidt M, Muller V, Holtrich U, Kaufmann M (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res 13(5):R97

    Article  PubMed  Google Scholar 

  37. Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ (2006) Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res 8(5):R61

    Article  PubMed  Google Scholar 

  38. Kibriya MG, Jasmine F, Roy S, Paul-Brutus RM, Argos M, Ahsan H (2010) Analyses and interpretation of whole-genome gene expression from formalin-fixed paraffin-embedded tissue: an illustration with breast cancer tissues. BMC Genomics 11:622

    Article  PubMed  Google Scholar 

  39. Mittempergher L, de Ronde JJ, Nieuwland M, Kerkhoven RM, Simon I, Rutgers EJ, Wessels LF, Van’t Veer LJ (2011) Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue. PLoS ONE 6(2):e17163

    Article  PubMed  CAS  Google Scholar 

  40. Ton CC, Vartanian N, Chai X, Lin MG, Yuan X, Malone KE, Li CI, Dawson A, Sather C, Delrow J, Hsu L, Porter PL (2011) Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Res Treat 125(3):879–883

    Article  PubMed  CAS  Google Scholar 

  41. Reinholz MM, Eckel-Passow JE, Anderson SK, Asmann YW, Zschunke MA, Oberg AL, McCullough AE, Dueck AC, Chen B, April CS, Wickham-Garcia E, Jenkins RB, Cunningham JM, Jen J, Perez EA, Fan JB, Lingle WL (2010) Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL(R) platform. BMC Med Genom 3:60

    Article  Google Scholar 

  42. Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knuchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG (2007) Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 26(38):5680–5691

    Article  PubMed  CAS  Google Scholar 

  43. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, Tokino T (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98(6):1147–1156

    Article  PubMed  CAS  Google Scholar 

  44. Ugolini F, Charafe-Jauffret E, Bardou VJ, Geneix J, Adelaide J, Labat-Moleur F, Penault-Llorca F, Longy M, Jacquemier J, Birnbaum D, Pebusque MJ (2001) WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 20(41):5810–5817

    Article  PubMed  CAS  Google Scholar 

  45. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyries S, Adelaide J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3(12):655–667

    Article  PubMed  CAS  Google Scholar 

  46. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C (1997) Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 57(19):4360–4367

    PubMed  CAS  Google Scholar 

  47. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z (2007) Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7:55

    Article  PubMed  Google Scholar 

  48. Kim H, Watkinson J, Varadan V, Anastassiou D (2010) Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genom 3:51

    Article  Google Scholar 

Download references

Acknowledgments

We thank all the patients and their families for the donation of samples for research. We thank Rebecca Johnston and Julie Johnson for excellent technical assistance. Ana Cristina Vargas was supported by a clinical fellowship from the Ludwig Institute for Cancer Research (LICR); Peter T Simpson is the recipient of a Fellowship from the National Breast Cancer Foundation, Australia. Georgia Chenevix-Trench is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia. This work was funded in part by grants from the LICR, the NHMRC, the Australian Medical Association Queensland and the Queensland Health Pathology Service—Study, Education and Research Trust Fund.

Conflict of interest

PTS received funding from Illumina to present at a conference about the WG-DASL assay. The remaining authors declare that they have no conflict of interest.

Author information

Author notes

  1. Leonard da Silva

    Present address: , Avenida Divino Salvador, 876, São Paulo, Brazil

Authors and Affiliations

  1. UQ Centre for Clinical Research, The University of Queensland, Herston, Brisbane, QLD, Australia

    Ana Cristina Vargas, Amy E. McCart Reed, Annette Lane, Lynne E. Reid, Chanel E. Smart, Leonard da Silva, Sarah Song, Peter T. Simpson & Sunil R. Lakhani

  2. Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD, Australia

    Nic Waddell & Sarah Song

  3. Queensland Institute for Medical Research, Herston, Brisbane, QLD, Australia

    Sibylle Cocciardi & Georgia Chenevix-Trench

  4. School of Medicine, The University of Queensland, Herston, QLD, Australia

    Sunil R. Lakhani

  5. Pathology Queensland, The Royal Brisbane and Women’s Hospital, Herston, QLD, Australia

    Sunil R. Lakhani

Authors
  1. Ana Cristina Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy E. McCart Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nic Waddell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annette Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lynne E. Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chanel E. Smart
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sibylle Cocciardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Leonard da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sarah Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Georgia Chenevix-Trench
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Peter T. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Sunil R. Lakhani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunil R. Lakhani.

Additional information

Ana Cristina Vargas and Amy E McCart Reed, and Peter T Simpson and Sunil R Lakhani contributed equally to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 1826 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vargas, A.C., Reed, A.E.M., Waddell, N. et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat 135, 153–165 (2012). https://doi.org/10.1007/s10549-012-2123-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-2123-4

Keywords

Search

Navigation